Primary Cells Global Market Size ($2.24 Billion Revenue By 2028) Growing Rapidly with Recent Trends and Outlook
Global primary cells market size is expected to reach $2.24 Bn by 2028 at a rate of 10.6%, segmented as by type, hematopoietic cells, dermatophytes, gastrointestinal cells, hepatocytes, lung cells
santhosh kumar Share this Post to earn Money ( Upto ₹100 per 1000 Views )
Overview and Scope
Primary cells refer to cells extracted directly from the living tissues of animals or people and then treated to prepare them for use in suitable cell treatments. These cells are employed in various applications, including 3D cell cultivation, virology, cancer research, stem cell treatment, and tissue restoration.
Sizing and Forecast
The primary cells market size has grown rapidly in recent years. It will grow from $1.33 billion in 2023 to $1.49 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to rising prevalence of cancer, increasing investments in regenerative medicine research, growing demand for monoclonal antibodies, advantages of primary human cells over cell lines, increasing prevalence of chronic diseases.
The primary cells market size is expected to see rapid growth in the next few years. It will grow to $2.24 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing focus on stem cell research, rising investments, increasing adoption of cell-based assays. Major trends in the forecast period include demand for human primary cells, advancements in research tools and technologies, adoption of cell-based therapies.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/primary-cells-global-market-report
Segmentation & Regional Insights
The primary cells market covered in this report is segmented –
1) By Type: Hematopoietic cells, Dermatophytes, Gastrointestinal Cells, Hepatocytes, Lung Cells, Renal Cells, Heart Cells, Musculoskeletal Cells, Other Primary Cells
2) By Origin: Human Primary Cells, Animal Primary Cells
3) By End User: Pharmaceuticals, Biotechnology Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Other End Users
North America was the largest region in the primary cells market in 2023. The regions covered in the primary cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14165&type=smp
Major Driver Impacting Market Growth
The rising government funding for cancer research is expected to propel the growth of the primary cells market going forward. Funding refers to the financial support provided to a project, initiative, organization, or individual to enable its development, operation, or achievement of specific goals. Government funding is used in primary cells to support research projects, personnel support, equipment and infrastructure, training and education, regulatory compliance, and technology development. For instance, in May 2022, the American Institute for Cancer Research (AICR), a US-based large American cancer research organization, requested $49 billion funding in 2023, which is an increase of $4.1 billion compared to the previous year's $46.4 billion. Therefore, rising government funding for cancer research is expected to propel the growth of the primary cell market.
Key Industry Players
Major companies operating in the primary cells market are Thermo Fisher Scientific Inc, Merck KGaA , BD Biosciences, Corning Incorporated, Cytiva, Lonza Group Ltd, Charles River Laboratories Inc., STEMCELL Technologies Inc, American Type Culture Collection , Cell Signaling Technology, BioIVT, InvivoGen, HemaCare Corporation, Creative Bioarray Inc., PromoCell GmbH, CellGenix, AllCells LLC, Axol Bioscience Ltd, PBS Biotech Inc, AnaBios Corporation, ReachBio Research Labs, PELOBIOTECH GmbH, Cell Biologics Inc., ZenBio Inc., StemBioSys Inc
The primary cells market report table of contents includes:
1. Executive Summary
2. Primary Cells Market Report Structure
3. Primary Cells Market Trends And Strategies
4. Primary Cells Market – Macro Economic Scenario
5. Primary Cells Market Size And Growth
…...
27. Primary Cells Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/gluten-feed-market
https://topprnews.com/organic-feed-market
https://topprnews.com/organic-pigments-market
https://goodprnews.com/rapeseed-oil-market
https://goodprnews.com/gluten-feed-market
https://goodprnews.com/manufactured-soil-market
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info
Healthcare Blog: https://healthcareresearchreports.com
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
